NL7317644A - - Google Patents

Info

Publication number
NL7317644A
NL7317644A NL7317644A NL7317644A NL7317644A NL 7317644 A NL7317644 A NL 7317644A NL 7317644 A NL7317644 A NL 7317644A NL 7317644 A NL7317644 A NL 7317644A NL 7317644 A NL7317644 A NL 7317644A
Authority
NL
Netherlands
Application number
NL7317644A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7317644A publication Critical patent/NL7317644A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
NL7317644A 1972-12-26 1973-12-21 NL7317644A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31805472A 1972-12-26 1972-12-26

Publications (1)

Publication Number Publication Date
NL7317644A true NL7317644A (es) 1974-06-28

Family

ID=23236430

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7317644A NL7317644A (es) 1972-12-26 1973-12-21

Country Status (5)

Country Link
JP (1) JPS4994820A (es)
BE (1) BE809060A (es)
DE (1) DE2364470A1 (es)
FR (1) FR2211215A1 (es)
NL (1) NL7317644A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115645A (en) * 1977-05-10 1978-09-19 Eli Lilly And Company Decolorizing process for 7-amino-3-(((2-methyl-1,3,4-thiadiazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid
JPS635091A (ja) * 1986-06-26 1988-01-11 Senjiyu Seiyaku Kk 着色防止方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1272453A (fr) * 1954-08-02 1961-09-29 Merck & Co Inc Procédé de stabilisation de solutions aqueuses de streptomycine

Also Published As

Publication number Publication date
BE809060A (fr) 1974-06-21
DE2364470A1 (de) 1974-06-27
FR2211215A1 (en) 1974-07-19
FR2211215B1 (es) 1977-09-09
JPS4994820A (es) 1974-09-09

Similar Documents

Publication Publication Date Title
FR2175922B1 (es)
FR2172071A1 (es)
FR2211215B1 (es)
JPS4963122U (es)
JPS5241021B2 (es)
JPS4984668U (es)
JPS4975053A (es)
JPS4938782U (es)
JPS4932546A (es)
JPS494680U (es)
JPS5330787Y2 (es)
JPS5033285Y1 (es)
JPS4995384U (es)
JPS4911702U (es)
JPS4896167U (es)
JPS48103996U (es)
CH601157A5 (es)
CH582640A5 (es)
CH965672A4 (es)
CH607068A5 (es)
CH606470A5 (es)
CH605725A5 (es)
CH602631A5 (es)
CH579074A5 (es)
CH596135A5 (es)